DE   EN   ES   FR   IT   PT


medicalmeds.eu Medicines Means the improving brain blood stream. Vinpotsetin-AKOS

Vinpotsetin-AKOS

Препарат Винпоцетин-АКОС. ОАО "Синтез" Россия


Producer: JSC Sintez Russia

Code of automatic telephone exchange: N06BX18

Release form: Liquid dosage forms. Solution for injections.

Indications to use: Ischemic stroke. Hemorrhagic stroke. Tranzitorny ischemic attack. Vascular dementia. Atherosclerosis. Hypertensive encephalopathy. Menyer's disease. Sonitus.


General characteristics. Structure:

Active agent: Vinpocetine of 5,0 mg. Excipients: ascorbic acid - 0,5 mg, benzyl alcohol - 10,0 mg, sorbitol (sorbite) - 100,0 mg, tartaric acid - 5,0 mg, sodium disulphite (sodium metabisulphite) - 1,0 mg, water for injections - to 1 ml.




Pharmacological properties:

Pharmacodynamics. Improves metabolism of a brain, increasing consumption of glucose and oxygen brain tissue. Increases resistance of neurons to a hypoxia; strengthens glucose transport to a brain through a blood-brain barrier; transfers process of disintegration of glucose to energetically more economical, aerobic way; selectively blocks kaltsiyzavisimy phosphodiesterase; increases concentration of adenosinemonophosphate (AMF), a cyclic guanozinmonofosfat (tsGMF) and adenosinetriphosphate (ATP) in a brain. Strengthens exchange of noradrenaline and serotonin in a brain, has antioxidant effect. Reduces aggregation of thrombocytes and the increased viscosity of blood; increases the deforming ability of erythrocytes and blocks utilization by adenosine erythrocytes; promotes increase in return of oxygen erythrocytes. Improves a brain blood stream; reduces resistance of vessels of a brain without essential change of indicators of system blood circulation. Does not render effect of "burglarizing" and strengthens blood supply, first of all, in ischemic sites of a brain. Gets through a placental barrier.

Pharmacokinetics. Therapeutic concentration at parenteral administration in plasma - 10-20 ng/ml, distribution volume – 5,3 l/kg. Communication with proteins of plasma – 66%, clearance – 66,7 l/h, exceeds the plasma volume of a liver (50 l/h) that demonstrates extrarenal metabolism. The elimination half-life makes 4-5 h. Easily gets through gistogematichesky barriers (including a blood-brain barrier), into breast milk (about 0,25% during 1 h). It is removed by kidneys and intestines in the ratio 3: 2.


Indications to use:

- reduction of expressiveness of neurologic and mental symptoms at various forms of insufficiency of cerebral circulation (including an ischemic stroke, a recovery stage of a hemorrhagic stroke, an effect of the had stroke; tranzitorny ischemic attack; vascular dementia; vertebrobazilyarny insufficiency; atherosclerosis of vessels of a brain; posttraumatic and hypertensive encephalopathy);
- chronic diseases of a choroid of an eye and vessels of a retina (including occlusion of the central artery or vein of a retina);
- decrease in auditory acuity of perceptual type, Menyer's disease, idiopathic sonitus.


Route of administration and doses:

Drug is intended only for intravenous drop infusion, to enter slowly (speed of infusion should not exceed 80 thaws/min.). For infusion preparation 
it is possible to use the solution of sodium of chloride of 0,9% or solutions containing a dextrose. 
Initial daily dose of 20 mg in 500 ml of solution of sodium of chloride of 0,9% or the solutions containing a dextrose. At good tolerance within 2-3 days, the dose is raised to maximum – 1 mg/kg/days.
The average duration of treatment is 10-14 days. 
At diseases of a liver or kidneys of dose adjustment it is not required.


Features of use:

At parenteral administration by a sick diabetes mellitus it is necessary to control the content of glucose in blood since solution contains sorbitol, patients with cardial pathology cannot enter in/in because of danger of development of arrhythmia (up to fibrillation of ventricles).


Side effects:

Decrease in the ABP. Seldom - tachycardia, premature ventricular contraction, delay of intra ventricular conductivity. At parenteral administration: dizziness, feeling of heat, a dermahemia of the person, nausea, thrombophlebitis in an injection site. Overdose. Treatment: gastric lavage, reception of absorbent carbon, symptomatic treatment.


Interaction with other medicines:

Increases risk of development of hemorrhagic complications against the background of a geparinoterapiya. Vinpocetine solution for injections pharmaceutical is incompatible with heparin.


Contraindications:

- an acute phase of a hemorrhagic stroke, heavy coronary heart disease, heavy disturbances of a heart rhythm, hypersensitivity to any of drug components;
- pregnancy (perhaps placental bleeding and spontaneous abortions probably as a result of strengthening of placental blood supply);
- breastfeeding period;
- age up to 18 years.
Before drug use surely consult with the doctor. 
Use at pregnancy Use at pregnancy is contraindicated.
In the period of a lactation it is necessary to stop breastfeeding.



Storage conditions:

In the place protected from light, at a temperature from 15 to 25 °C. To store in the places unavailable to children. 
Period of validity 3 years. Not to use after the period of validity specified on packaging.


Issue conditions:

According to the recipe


Packaging:

In a cardboard pack of 10 ampoules complete with an ampoule knife.



Similar drugs

Препарат Винпоцетин амп. 5 мг/мл 2 мл №10. ОАО "Синтез" Россия

Amp Vinpocetine. 5 mg/ml 2 ml No.

The means operating on a nervous system.



Препарат Кавинтон. ОАО "Синтез" Россия

Cavintonum

Nootropic drugs.



Препарат Винпоцетин таб. 0,005 №50. ОАО "Синтез" Россия

Vinpocetine таб. 0,005 No.

The means improving cerebral circulation.



Препарат Винпосан®. ОАО "Синтез" Россия

Винпосан®

Psychogogic and nonotropny means.



Препарат Винпоцетин-Дарница. ОАО "Синтез" Россия

Vinpotsetin-Darnitsa

The means operating on a nervous system.



Препарат Виннер-ЛФ. ОАО "Синтез" Россия

Vinner-LF

The drug improving blood circulation and metabolism of a brain.



Препарат Винпосан®. ОАО "Синтез" Россия

Винпосан®

Psychogogic and nonotropny means.



Препарат Вицеброл. ОАО "Синтез" Россия

Vitsebrol

Psychogogic and nonotropny means.



Препарат Винпоцетин. ОАО "Синтез" Россия

Vinpocetine

Nootropic drugs.



Препарат Винпоцетин 0,01%. ОАО "Синтез" Россия

Vinpocetine of 0,01%

The means improving cerebral circulation.



Препарат Винпоцетин. ОАО "Синтез" Россия

Vinpocetine

The means operating on a nervous system.



Препарат Винпоцетин форте. ОАО "Синтез" Россия

Vinpocetine forte

Means the improving brain blood stream.



Препарат Винпоцетин-Фармак. ОАО "Синтез" Россия

Vinpotsetin-Pharmak

Psychogogic and nonotropny means.



Препарат Винпоцетин-Сар®. ОАО "Синтез" Россия

Винпоцетин-Сар®

Means the improving brain blood stream.



Препарат Телектол®. ОАО "Синтез" Россия

Телектол®

Tserebrovazodilatiruyushchy means.





  • Сайт детского здоровья